Literature DB >> 35391797

MultiGATAE: A Novel Cancer Subtype Identification Method Based on Multi-Omics and Attention Mechanism.

Ge Zhang1, Zhen Peng1, Chaokun Yan1, Jianlin Wang1, Junwei Luo2, Huimin Luo1.   

Abstract

Cancer is one of the leading causes of death worldwide, which brings an urgent need for its effective treatment. However, cancer is highly heterogeneous, meaning that one cancer can be divided into several subtypes with distinct pathogenesis and outcomes. This is considered as the main problem which limits the precision treatment of cancer. Thus, cancer subtypes identification is of great importance for cancer diagnosis and treatment. In this work, we propose a deep learning method which is based on multi-omics and attention mechanism to effectively identify cancer subtypes. We first used similarity network fusion to integrate multi-omics data to construct a similarity graph. Then, the similarity graph and the feature matrix of the patient are input into a graph autoencoder composed of a graph attention network and omics-level attention mechanism to learn embedding representation. The K-means clustering method is applied to the embedding representation to identify cancer subtypes. The experiment on eight TCGA datasets confirmed that our proposed method performs better for cancer subtypes identification when compared with the other state-of-the-art methods. The source codes of our method are available at https://github.com/kataomoi7/multiGATAE.
Copyright © 2022 Zhang, Peng, Yan, Wang, Luo and Luo.

Entities:  

Keywords:  cancer subtype identification; cluster; graph attention network; multi-omics; omics-level attention mechanism

Year:  2022        PMID: 35391797      PMCID: PMC8979770          DOI: 10.3389/fgene.2022.855629

Source DB:  PubMed          Journal:  Front Genet        ISSN: 1664-8021            Impact factor:   4.599


  25 in total

Review 1.  Molecular subtyping of cancer: current status and moving toward clinical applications.

Authors:  Lan Zhao; Victor H F Lee; Michael K Ng; Hong Yan; Maarten F Bijlsma
Journal:  Brief Bioinform       Date:  2019-03-25       Impact factor: 11.622

2.  A fully Bayesian latent variable model for integrative clustering analysis of multi-type omics data.

Authors:  Qianxing Mo; Ronglai Shen; Cui Guo; Marina Vannucci; Keith S Chan; Susan G Hilsenbeck
Journal:  Biostatistics       Date:  2018-01-01       Impact factor: 5.899

3.  Deep latent space fusion for adaptive representation of heterogeneous multi-omics data.

Authors:  Chengming Zhang; Yabin Chen; Tao Zeng; Chuanchao Zhang; Luonan Chen
Journal:  Brief Bioinform       Date:  2022-03-10       Impact factor: 11.622

4.  Similarity network fusion for aggregating data types on a genomic scale.

Authors:  Bo Wang; Aziz M Mezlini; Feyyaz Demir; Marc Fiume; Zhuowen Tu; Michael Brudno; Benjamin Haibe-Kains; Anna Goldenberg
Journal:  Nat Methods       Date:  2014-01-26       Impact factor: 28.547

5.  MCNF: A Novel Method for Cancer Subtyping by Integrating Multi-Omics and Clinical Data.

Authors:  Lan Zhao; Hong Yan
Journal:  IEEE/ACM Trans Comput Biol Bioinform       Date:  2019-04-11       Impact factor: 3.710

6.  Pattern fusion analysis by adaptive alignment of multiple heterogeneous omics data.

Authors:  Qianqian Shi; Chuanchao Zhang; Minrui Peng; Xiangtian Yu; Tao Zeng; Juan Liu; Luonan Chen
Journal:  Bioinformatics       Date:  2017-09-01       Impact factor: 6.937

7.  Simultaneous Interrogation of Cancer Omics to Identify Subtypes With Significant Clinical Differences.

Authors:  Aodan Xu; Jiazhou Chen; Hong Peng; GuoQiang Han; Hongmin Cai
Journal:  Front Genet       Date:  2019-03-28       Impact factor: 4.599

8.  Comprehensive genomic characterization defines human glioblastoma genes and core pathways.

Authors: 
Journal:  Nature       Date:  2008-09-04       Impact factor: 49.962

Review 9.  A Comprehensive Survey on Graph Neural Networks.

Authors:  Zonghan Wu; Shirui Pan; Fengwen Chen; Guodong Long; Chengqi Zhang; Philip S Yu
Journal:  IEEE Trans Neural Netw Learn Syst       Date:  2021-01-04       Impact factor: 10.451

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.